Parametasona and clorfenamina THERAPEUTIC INDICATIONS: Oral treatment of the allergic affections. DILARMINE combines the antiallergic, antirheumatic and anti-inflammatory properties of acetate of parametasona with the maleato of clorfenamina, an antihistamine one of fast well tolerated action and, consequently a greater antiallergic power by the synergy of its components is obtained. DILARMINE is indicated in the treatment of allergic inflammatory affections, particularly those that attend with prurito; reason why it is recommended in: atópica dermatitis, dermatitis by contact, edema angioneurótico, eccematoide dermatitis, serious seborreica dermatitis, neurodermatitis (including circumscribed neurodermatitis), multiform, urticaria erythema, puncture of insects, fever of the seasonal hay and others rinitis, vasomotor perennial allergy, rinitis, bronchial asthma, medicinal reactions, allergic ocular manifestations like: conjuntivitis and iridociclitis. Dilarmine may also be used for purposes other than those listed in this medication guide. Please consult your physician before taking any medication.
IMPORTANT NOTE: The preceding information is intended to heighten awareness of health information and does not suggest diagnosis or treatment. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.